Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma With MYCN Amplification Plus 11q Deletion

PLoS ONE - United States
doi 10.1371/journal.pone.0053740
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

cDNA Array-CGH Profiling Identifies Genomic Alterations Specific to Stage and MYCN-amplification in Neuroblastoma

BMC Genomics
BiotechnologyGenetics
2004English

Intratumoral Heterogeneity of HER-2 Gene Amplification and Protein Overexpression in Breast Cancer

Human Pathology
Forensic MedicinePathology
2010English

LMO1 Synergizes With MYCN to Promote Neuroblastoma Initiation and Metastasis

Cancer Cell
Cancer ResearchOncologyCell Biology
2017English

MYCN Gene Amplification Is a Powerful Prognostic Factor Even in Infantile Neuroblastoma Detected by Mass Screening

British Journal of Cancer
Cancer ResearchOncology
2006English

The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Epigenetic Regulation of the Neuroblastoma Genes, Arid3b and Mycn

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Phox2B Correlates With MYCN and Is a Prognostic Marker for Neuroblastoma Development

Oncology Letters
Cancer ResearchOncology
2015English

Craniosynostosis and Syndactyly: Expanding the 11q-- Chromosomal Deletion Phenotype.

Journal of Medical Genetics
Genetics
1980English

ABCC4/MRP4: A MYCN-regulated Transporter and Potential Therapeutic Target in Neuroblastoma

Frontiers in Oncology
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy